Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy.

作者: Maria Csobonyeiova , Stefan Polak , Lubos Danisovic

DOI: 10.3390/IJMS21062239

关键词: Induced pluripotent stem cellNeuroscienceStem cellCell typeDiseaseHuntington's diseaseDegenerative diseaseNeural cellCognitive declineMedicine

摘要: Huntington’s disease (HD) is an inherited, autosomal dominant, degenerative characterized by involuntary movements, cognitive decline, and behavioral impairment ending in death. HD caused expansion the number of CAG repeats huntingtin gene on chromosome 4. To date, no effective therapy for preventing onset or progression has been found, many symptoms do not respond to pharmacologic treatment. However, recent results pre-clinical trials suggest a beneficial effect stem-cell-based therapy. Induced pluripotent stem cells (iPSCs) represent unlimited cell source are most suitable among various types autologous due their patient specificity ability differentiate into variety both vitro vivo. Furthermore, cultivation iPSC-derived neural offers possibility studying etiopathology neurodegenerative diseases, such as HD. Moreover, differentiated can organize three-dimensional (3D) organoids, mimicking complex architecture brain. In this article, we present comprehensive review models, methods differentiating HD–iPSCs desired types, progress editing techniques leading toward

参考文章(72)
Feng-Lan Chiu, Jun-Tasi Lin, Ching-Yu Chuang, Ting Chien, Chiung-Mei Chen, Kai-Hsiang Chen, Han-Yun Hsiao, Yow-Sien Lin, Yijuang Chern, Hung-Chih Kuo, Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs Human Molecular Genetics. ,vol. 24, pp. 6066- 6079 ,(2015) , 10.1093/HMG/DDV318
C. Kay, N.H. Skotte, A.L. Southwell, M.R. Hayden, Personalized gene silencing therapeutics for Huntington disease Clinical Genetics. ,vol. 86, pp. 29- 36 ,(2014) , 10.1111/CGE.12385
Michael P. Schwartz, Zhonggang Hou, Nicholas E. Propson, Jue Zhang, Collin J. Engstrom, Vitor Santos Costa, Peng Jiang, Bao Kim Nguyen, Jennifer M. Bolin, William Daly, Yu Wang, Ron Stewart, C. David Page, William L. Murphy, James A. Thomson, Human pluripotent stem cell-derived neural constructs for predicting neural toxicity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 12516- 12521 ,(2015) , 10.1073/PNAS.1516645112
Alessia Delli Carri, Marco Onorati, Valentina Castiglioni, Andrea Faedo, Stefano Camnasio, Mauro Toselli, Gerardo Biella, Elena Cattaneo, Human Pluripotent Stem Cell Differentiation into Authentic Striatal Projection Neurons Stem Cell Reviews and Reports. ,vol. 9, pp. 461- 474 ,(2013) , 10.1007/S12015-013-9441-8
Jeffrey B Carroll, Simon C Warby, Amber L Southwell, Crystal N Doty, Sarah Greenlee, Niels Skotte, Gene Hung, C Frank Bennett, Susan M Freier, Michael R Hayden, Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin Molecular Therapy. ,vol. 19, pp. 2178- 2185 ,(2011) , 10.1038/MT.2011.201
Stefano Camnasio, Alessia Delli Carri, Angelo Lombardo, Iwona Grad, Caterina Mariotti, Alessia Castucci, Björn Rozell, Pietro Lo Riso, Valentina Castiglioni, Chiara Zuccato, Christelle Rochon, Yasuhiro Takashima, Giuseppe Diaferia, Ida Biunno, Cinzia Gellera, Marisa Jaconi, Austin Smith, Outi Hovatta, Luigi Naldini, Stefano Di Donato, Anis Feki, Elena Cattaneo, The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiology of Disease. ,vol. 46, pp. 41- 51 ,(2012) , 10.1016/J.NBD.2011.12.042
Julia A. Kaye, Steven Finkbeiner, Modeling Huntington's disease with induced pluripotent stem cells Molecular and Cellular Neuroscience. ,vol. 56, pp. 50- 64 ,(2013) , 10.1016/J.MCN.2013.02.005
Yiju Chen, Richard L. Carter, In K. Cho, Anthony W.S. Chan, Cell-based therapies for Huntington's disease Drug Discovery Today. ,vol. 19, pp. 980- 984 ,(2014) , 10.1016/J.DRUDIS.2014.02.012
Y Zhang, R M Friedlander, Using non-coding small RNAs to develop therapies for Huntington's disease Gene Therapy. ,vol. 18, pp. 1139- 1149 ,(2011) , 10.1038/GT.2011.170
Madeline A Lancaster, Juergen A Knoblich, Generation of cerebral organoids from human pluripotent stem cells Nature Protocols. ,vol. 9, pp. 2329- 2340 ,(2014) , 10.1038/NPROT.2014.158